Drug Development Overview

Level 2

  • 1

    Module1: Drug Discovery and Pre-Clinical Testing

    • Module 1
  • 2

    Module 2: Overview of Development in Humans

    • Module 2: Overview of Development in Humans
  • 3

    Module 3: Market Drivers – the risks and benefits of drug development

    • Module 3: Market Drivers – the risks and benefits of drug development

Instructor

Chief Operating Officer

Dr Tina Barton

Dr. Tina Barton, Chief Operating Officer of eMQT, is a drug development specialist with over 40 years’ experience, working in partnership to lead for success as a customer-focused senior leader. During this time Dr. Barton has invested in training for the future – through team leadership, individual mentoring and training thereby sharing knowledge and developing professionals. Through her role at the Institute of Clinical Research she continues to support and lead training activities. With a passion for transformation, Dr. Barton drove the embracement of Central Eastern European countries and now is focused on the inclusion of Sub-Saharan Africa into clinical development – bringing the miracle of development of new medicines to emerging markets and new patients. Dr. Barton holds a BSc, PhD and MBA alongside over 50 academic publications and is an Honorary Fellow, and Board Member of the Institute of Clinical Research.